A community pharmacist intervention for people living with epilepsy

IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Journal of the American Pharmacists Association Pub Date : 2024-10-28 DOI:10.1016/j.japh.2024.102275
Jennifer L. Bacci, Ifechukwu Benedict Nwogu, Sabra Zaraa, Michelle Guignet, H. Steve White, Andy Stergachis, Derek Ems, Edward J. Novotny
{"title":"A community pharmacist intervention for people living with epilepsy","authors":"Jennifer L. Bacci,&nbsp;Ifechukwu Benedict Nwogu,&nbsp;Sabra Zaraa,&nbsp;Michelle Guignet,&nbsp;H. Steve White,&nbsp;Andy Stergachis,&nbsp;Derek Ems,&nbsp;Edward J. Novotny","doi":"10.1016/j.japh.2024.102275","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Epilepsy is a complex spectrum of seizure disorders. Antiseizure medications are the first-line treatment for most patients. Community pharmacists are among the most accessible health care providers with extensive knowledge of pharmacotherapy yet are seldom engaged in epilepsy care.</div></div><div><h3>Objective</h3><div>The objective of this project was to pilot a community pharmacist-led intervention for people living with epilepsy (PWE).</div></div><div><h3>Methods</h3><div>The Community Pharmacist Epilepsy Services Program was a 6-month disease state management intervention that included 4 components: patient-pharmacist consultation, care plan development, regular check-ins, and care coordination. A pilot was conducted in 4 independent community pharmacies (2 intervention and 2 comparator) in western Washington State. A prospective, 2-arm, pre-post study was planned to evaluate the impact of the intervention on patient-reported quality of life (QoL), health, and satisfaction outcomes. The approach shifted to a 1-arm pre-post design due to low patient recruitment. The primary QoL outcome was the patient-weighted Quality of Life in Epilepsy Inventory-10 (QOLIE-10-P). Staff at intervention and comparator pharmacies were surveyed to evaluate perceived barriers to patient recruitment.</div></div><div><h3>Results</h3><div>Ten patients, including 7 intervention and 3 usual care patients, enrolled in the study. Five intervention patients completed the pre- and postsurveys. The median pre-QOLIE-10-P score was 1.09 and the median postscore was 1.73, indicating a slight nonsignificant decrease in QoL. Eleven pharmacy staff completed the survey evaluating perceived patient recruitment barriers. Limited number of eligible PWE at each pharmacy was perceived as significant barriers.</div></div><div><h3>Conclusion</h3><div>While low patient enrollment limited the ability to observe trends and draw conclusions about the potential impact of the intervention, enrollment barriers and lessons learned highlight opportunities to refine the intervention with the goal of improving the outcomes and well-being of PWE.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"65 1","pages":"Article 102275"},"PeriodicalIF":2.5000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Pharmacists Association","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1544319124003066","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Epilepsy is a complex spectrum of seizure disorders. Antiseizure medications are the first-line treatment for most patients. Community pharmacists are among the most accessible health care providers with extensive knowledge of pharmacotherapy yet are seldom engaged in epilepsy care.

Objective

The objective of this project was to pilot a community pharmacist-led intervention for people living with epilepsy (PWE).

Methods

The Community Pharmacist Epilepsy Services Program was a 6-month disease state management intervention that included 4 components: patient-pharmacist consultation, care plan development, regular check-ins, and care coordination. A pilot was conducted in 4 independent community pharmacies (2 intervention and 2 comparator) in western Washington State. A prospective, 2-arm, pre-post study was planned to evaluate the impact of the intervention on patient-reported quality of life (QoL), health, and satisfaction outcomes. The approach shifted to a 1-arm pre-post design due to low patient recruitment. The primary QoL outcome was the patient-weighted Quality of Life in Epilepsy Inventory-10 (QOLIE-10-P). Staff at intervention and comparator pharmacies were surveyed to evaluate perceived barriers to patient recruitment.

Results

Ten patients, including 7 intervention and 3 usual care patients, enrolled in the study. Five intervention patients completed the pre- and postsurveys. The median pre-QOLIE-10-P score was 1.09 and the median postscore was 1.73, indicating a slight nonsignificant decrease in QoL. Eleven pharmacy staff completed the survey evaluating perceived patient recruitment barriers. Limited number of eligible PWE at each pharmacy was perceived as significant barriers.

Conclusion

While low patient enrollment limited the ability to observe trends and draw conclusions about the potential impact of the intervention, enrollment barriers and lessons learned highlight opportunities to refine the intervention with the goal of improving the outcomes and well-being of PWE.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
社区药剂师对癫痫患者的干预。
背景:癫痫是一种复杂的发作性疾病。抗癫痫药物 (ASM) 是大多数患者的一线治疗药物。社区药剂师是最容易获得的医疗服务提供者之一,拥有丰富的药物治疗知识,但却很少参与癫痫护理:本项目的目的是为癫痫患者(PWE)试行一项由社区药剂师主导的干预措施:社区药剂师癫痫服务计划是一项为期 6 个月的疾病状态管理干预措施,包括 4 个组成部分:患者-药剂师咨询、护理计划制定、定期检查和护理协调。在华盛顿州西部的 4 家独立社区药房(2 家干预药房和 2 家比较药房)进行了试点。计划开展一项前瞻性、双臂、前-后研究,以评估干预措施对患者报告的生活质量(QoL)、健康和满意度结果的影响。由于招募的患者人数较少,研究方法改为单臂、前-后设计。主要的生活质量结果是患者加权的癫痫生活质量量表-10(QOLIE-10-P)。对干预药房和比较药房的员工进行了调查,以评估他们在招募患者时遇到的障碍:10名患者参加了研究,其中包括7名干预患者和3名常规护理患者。五名干预患者完成了前后调查。前QOLIE-10-P得分中位数为1.09,后得分中位数为1.73,表明QoL略有下降,但不明显。11 名药剂师完成了评估患者招募障碍的调查。每家药房符合条件的病患人数有限被认为是重大障碍:虽然患者招募率低限制了观察趋势和得出干预潜在影响结论的能力,但招募障碍和吸取的经验教训凸显了完善干预的机会,其目标是改善 PWE 的结果和福祉。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.30
自引率
14.30%
发文量
336
审稿时长
46 days
期刊介绍: The Journal of the American Pharmacists Association is the official peer-reviewed journal of the American Pharmacists Association (APhA), providing information on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion, and original research. JAPhA publishes original research, reviews, experiences, and opinion articles that link science to contemporary pharmacy practice to improve patient care.
期刊最新文献
Implementing a Telemedicine-led Heart Failure Medication Regimen Optimization Clinic in Medically Underserved Heart Failure Populations. Exploring the pharmacist role in insomnia management and care provision: A scoping review. Long-Term Opioid Therapy in Older Adults: Incidence and Risk Factors Related to Patient Characteristics and Initial Opioid Dispensed. Pharmacists Enhance National Security through Medical Countermeasure Program Leadership. Barriers to and Facilitators of Buprenorphine Dispensing for Opioid Use Disorder: Evidence from Focus Groups in Appalachian Kentucky.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1